Chimeric antigen receptor T cell (CAR-T)-based therapy, using engineered T cells to fight cancer, is a transformative technology that may forever change the landscape of medicine. However, for researchers developing cell-based therapies, delving into the complexities of the immune system can be challenging, especially when using traditional screening and profiling methods.Recent advances in assay technology, however, are beginning to transform CAR-T discovery and development. These advances provide the speed and sensitivity to support high-throughput, cost effective analysis, and generate deeper, more biologically relevant insights to get you to actionable results faster.
Download this application compendium to discover how advanced flow cytometry enables you to advance and accelerate CAR-T discovery with:
To learn more about information-rich solutions for CAR-T research from Sartorius, visit www.sartorius.com/car-t-research.
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.